发明名称 USE OF THYMOSIN ALPHA 1 FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF STAGE IV MALIGNANT MELANOMA.
摘要 <p>It is described the use of thymosin alpha in combination with dacarbazine and optionally with Interferon alpha, for preparing a medicament for the treatment of malignant melanoma on stage IV characterized by distant unresectable metastases.</p>
申请公布号 MX2008015145(A) 申请公布日期 2008.12.15
申请号 MX20080015145 申请日期 2007.04.17
申请人 SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. 发明人 PAOLO CARMINATI;ROBERTO CAMERINI
分类号 A61K38/22;A61K31/4164;A61P35/00 主分类号 A61K38/22
代理机构 代理人
主权项
地址